MicroRNAs in kidney injury and disease
N Mahtal, O Lenoir, C Tinel, D Anglicheau… - Nature Reviews …, 2022 - nature.com
MicroRNAs (miRNAs) are small non-coding RNAs that regulate gene expression by
degrading or repressing the translation of their target messenger RNAs. As miRNAs are …
degrading or repressing the translation of their target messenger RNAs. As miRNAs are …
Role of macrophages and related cytokines in kidney disease
E Cantero-Navarro, S Rayego-Mateos… - Frontiers in …, 2021 - frontiersin.org
Inflammation is a key characteristic of kidney disease, but this immune response is two-
faced. In the acute phase of kidney injury, there is an activation of the immune cells to fight …
faced. In the acute phase of kidney injury, there is an activation of the immune cells to fight …
Extracellular vesicles and exosomes generated from cystic renal epithelial cells promote cyst growth in autosomal dominant polycystic kidney disease
H Ding, LX Li, PC Harris, J Yang, X Li - Nature communications, 2021 - nature.com
Autosomal dominant polycystic kidney disease (ADPKD) is caused by germline mutations of
PKD1 or PKD2 on one allele and a somatic mutation inactivating the remaining normal …
PKD1 or PKD2 on one allele and a somatic mutation inactivating the remaining normal …
Discovery and preclinical evaluation of anti-miR-17 oligonucleotide RGLS4326 for the treatment of polycystic kidney disease
EC Lee, T Valencia, C Allerson, A Schairer… - Nature …, 2019 - nature.com
Autosomal dominant polycystic kidney disease (ADPKD), caused by mutations in either
PKD1 or PKD2 genes, is one of the most common human monogenetic disorders and the …
PKD1 or PKD2 genes, is one of the most common human monogenetic disorders and the …
[HTML][HTML] microRNA-17 family promotes polycystic kidney disease progression through modulation of mitochondrial metabolism
Autosomal dominant polycystic kidney disease (ADPKD) is the most frequent genetic cause
of renal failure. Here we identify miR-17 as a target for the treatment of ADPKD. We report …
of renal failure. Here we identify miR-17 as a target for the treatment of ADPKD. We report …
PPARα agonist fenofibrate enhances fatty acid β-oxidation and attenuates polycystic kidney and liver disease in mice
Peroxisome proliferator-activated receptor α (PPARα) is a nuclear hormone receptor that
promotes fatty acid β-oxidation (FAO) and oxidative phosphorylation (OXPHOS). We and …
promotes fatty acid β-oxidation (FAO) and oxidative phosphorylation (OXPHOS). We and …
[HTML][HTML] The function of miRNAs in the process of kidney development
P Sun, J Wang, T Ilyasova, A Shumadalova… - Non-coding RNA …, 2023 - Elsevier
MicroRNAs (miRNAs) are a class of small non-coding RNAs (ncRNAs) that typically consist
of 19–25 nucleotides in length. These molecules function as essential regulators of gene …
of 19–25 nucleotides in length. These molecules function as essential regulators of gene …
[HTML][HTML] Interstitial microRNA miR-214 attenuates inflammation and polycystic kidney disease progression
Renal cysts are the defining feature of autosomal dominant polycystic kidney disease
(ADPKD); however, the substantial interstitial inflammation is an often-overlooked aspect of …
(ADPKD); however, the substantial interstitial inflammation is an often-overlooked aspect of …
Emerging therapies for autosomal dominant polycystic kidney disease with a focus on cAMP signaling
X Zhou, VE Torres - Frontiers in Molecular Biosciences, 2022 - frontiersin.org
Autosomal dominant polycystic kidney disease (ADPKD), with an estimated genetic
prevalence between 1: 400 and 1: 1,000 individuals, is the third most common cause of end …
prevalence between 1: 400 and 1: 1,000 individuals, is the third most common cause of end …
Molecular mechanisms of epigenetic regulation, inflammation, and cell death in ADPKD
E Agborbesong, LX Li, L Li, X Li - Frontiers in Molecular Biosciences, 2022 - frontiersin.org
Autosomal dominant polycystic kidney disease (ADPKD) is a genetic disorder, which is
caused by mutations in the PKD1 and PKD2 genes, characterizing by progressive growth of …
caused by mutations in the PKD1 and PKD2 genes, characterizing by progressive growth of …